27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of mortality risk for causative agents

Burns

Volumn 39, Issue 7, 2013, Pages 1449-1455

  Weinand, C ^a   Xu, W ^a   Perbix, W ^a   Lefering, R ^a   Maegele, M ^b   Rathert, M ^a   Spilker, G ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Causing agent; Death; Relative risk; Stevens Johnson syndrome; TEN SJS overlap; Toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DICLOFENAC; DIPYRONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIMETABOLITE; CATECHOLAMINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; BODY SURFACE; BURN; BURN UNIT; DIALYSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK FACTOR; SAMPLE SIZE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; ADOLESCENT; AGE DISTRIBUTION; EPIDEMIOLOGY; GERMANY; INCIDENCE; LENGTH OF STAY; MIDDLE AGED; MORTALITY; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; STEVENS-JOHNSON SYNDROME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMETABOLITES; BURN UNITS; CATECHOLAMINES; FEMALE; GERMANY; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 84885430450     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2013.03.011     Document Type: Article

References (29)

1. M. Mockenhaupt The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis Expert Rev Clin Immunol 7 2011 803 815
2. B.S. Atiyeh, D.I. Kayle, and A.A. Nassar Burn like syndromes Ann Burn Fire Disaster 12 1999 39 43
3. T. Petkov, G. Pehlivanov, I. Grozdev, S. Kavaklieva, and N. Tsankov Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome Eur J Dermatol 17 2007 422 427
4. I.O. Fadeyibi, S.A. Ademiluyi, F.O. Ajose, P.I. Jewo, and O.I. Akinola Severe idiosyncratic drug reactions with epidermal necrolysis: a 5-year study Indian J Plast Surg 44 2011 467 473
5. L.E. French, J.T. Trent, and F.A. Kerdel Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding Int Immunopharmacol 6 2006 543 549
6. L. Cabral, F. Riobom, and C. Diogo Toxic epidermal necrolysis Ann Burn Fire Disasters 17 2004 90 102
7. J.C. Roujeau, J.C. Guillaume, J.P. Fabre, and D. Penso Toxic epidermal necrolysis: incidence and drug aethiology in France Arch Dermatol 126 1996 37 43
8. M. Lissia, P. Mulas, A. Bulla, and C. Rubino Toxic epidermal necrolysis (Lyell's disease) Burns 36 2010 152 163
9. M. Spies, A.P. Sanford, S.E. Wolf, J.F. Ail-Low, and D.N. Herndon Treatment of extensive toxic epidermal necrolysis in children Paediatrics 108 2001 1162 1168
10. R. Wolf, E. Orion, B. Marcos, and H. Matz Life-threatening acute adverse cutaneous drug reactions Clin Dermatol 23 2005 171 181
11. S. Bastuji-Garin, N. Fouchard, M. Bertocchi, J.C. Roujeau, P. Revuz, and P. Wolkenstein SCORTEN: a severity-of-illness score for toxic epidermal necrolysis J Invest Dermatol 115 2000 149 153
12. J. Tobiasen, J.H. Hiebert, and R.F. Edlich Prediction of burn mortality Surg Gynecol Obstet 154 May (5) 1982 711 714
13. M.F. Struck, P. Hilbert, M. Mockenhaupt, B. Reichelt, and M. Steen Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes Intensive Care Med 36 2010 22 32
14. M. Mockenhaupt Sever drug induced skin reactions: clinical pattern, diagnostic and therapy J Dtsch Dermatol Ges 7 2009 142 163
15. M. Mockenhaupt Severe cutaneous adverse reactions W.H.C. Burgdorf, G. Plewig, H.H. Wolff, M. Landthaler, Braun-Falco's dermatology 3rd ed. 2008 Springer Medizin Verlag Heidelberg, Germany 473 483
16. P.D. Ghislain, and J.C. Roujeau Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome Dermatol Online J 1 2002 5
17. Y. Araki, C. Sotozono, and T. Inatomi Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset Am J Opthalmol 147 2009 1004 1011
18. N. Bachot, J. Revuz, and J.C. Roujeau Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. A prospective noncomparative study showing no benefit on mortality or progression Arch Dermatol 139 2003 33 36
19. W. Peters, J. Zaidi, and L. Douglas Toxic epidermal necrolysis: a burn-center challenge Can Med Assoc J 144 1991 1477 1480
20. J. Kelemen, W. Cioffi, W. McManus, A. Mason, and B. Priutt Burn center care for patients with toxic epidermal necrolysis J Am Coll Surg 180 1995 273 278
21. T. McGee, and A. Munster Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center Plast Reconstr Surg 102 1998 1018 1022
22. J. Schulz, R. Sheridan, C. Ryan, B. MacKool, and R. Tompkins A 10-year experience with toxic epidermal necrolysis J Burn Care Rehabil 21 2000 199 204
23. P. Neff, C. Meuli-Simmen, W. Kempf, T. Gaspert, V.E. Meyer, and W. Künzi Lyell syndrome revisited: analysis of 18 cases of severe bullous skin disease in a burn unit Br J Plast Surg 58 2005 73 80
24. D.S. Becker Toxic epidermal necrolysis Lancet 351 1998 1417 1420
25. M. Mockenhaupt, C. Viboud, A. Dunant, L. Naldi, S. Halevy, J.N. Bouwes Bavinck, A. Sidoroff, J. Schneck, J.-C. Roujeau, and A. Flahault Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study J Invest Dermatol 128 2008 35 44
26. A. Sidoroff, A. Dunant, and C. Viboud Risk factors for acute generalized exanthematous pustolosis (AGEP) - results for a multinational case-control study (EuroSCAR) Br J Dermatol 157 2007 989 996
27. D.J. Fine Drug therapy: management of acquired bullous skin diseases N Eng J Med 333 1995 1475 1484
28. M. Stella, A. Clemente, D. Bollero, D. Risso, and P. Dalmasso Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis Burns 33 2007 452 459
29. T. Harr, and L.E. French Stevens-Johnson syndrome and toxic epidermal necrolysis L.E. French, Adverse cutaneous drug reactions vol. 97 2012 Chem Immunol Allergy Basel, Karger 149 166